TSC22D2 and pancreatic adenocarcinoma: The protein expression of TSC22D2 was significantly higher in PAAD samples (n = 137) than that in normal samples (n = 74) (p < 0.001), as shown in Fig. 7B. In addition, we analyzed the expression of TSC22D2 at the RNA level.